BeOne Medicines President & COO Sells $1.5M in ONC Stock
BeOne Medicines Ltd.
Subscribe to track ONC
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
BeOne Medicines President & COO Sells $1.5M in ONC Stock
Company: BeOne Medicines Ltd. (ONC) Form: 4 | Filed: 2025-11-19 Significance: Low
Insider: Wu Xiaobin Title: President and COO | Relationship: Officer
Transaction: • Type: Sale • Shares: 3,991 American Depositary Shares • Price: ~$380.43 (weighted avg.) • Value: $1,518,303 • Owned After: 12,365 (Direct ADS)
Key Insight: The sale represents a negligible fraction (0.00375%) of the company's $40.48B market cap, indicating it is likely for personal financial management rather than a change in outlook.
Market Context: This is a routine insider sale, unlikely to have a material impact on the stock price given its small size relative to the company's valuation.
This is PUBLIC SEC data for educational purposes. Not investment advice.
Comprehensive Analysis
SEC Filing Analysis: BeOne Medicines Ltd. (ONC)
Executive Summary
- Trading Significance: Low
- Key Takeaway: The President and COO, Wu Xiaobin, sold approximately $1.52 million worth of American Depositary Shares (ADS), a transaction of low significance given the company's large market capitalization.
- Market Impact: The sale is too small to be considered material and is expected to have a neutral impact on the stock.
Company Information
| Field | Value |
|---|---|
| Company | BeOne Medicines Ltd. |
| Ticker Symbol | ONC |
| CIK | 0001651308 |
| Industry | Pharmaceutical Preparations |
Insider Information
| Field | Value |
|---|---|
| Name | Wu Xiaobin |
| CIK | 0001739452 |
| Title/Position | President and COO |
| Relationship | Officer |
Transaction Details
| Field | Value |
|---|---|
| Form Type | 4 |
| Transaction Date | 2025-11-17 |
| Transaction Code | S (Sale) |
| Security Type | American Depositary Shares |
| Shares Involved | 3,991 |
| Price Per Share | $380.43 (Weighted Average) |
| Total Value | $1,518,303.37 |
| Shares Owned After | 12,365 (Directly owned ADS) |
| Ownership Type | Direct |
Financial Impact Assessment
Transaction Materiality
| Metric | Value |
|---|---|
| Transaction Value | $1,518,303.37 |
| % of Market Cap | 0.00375% |
| Shares Transacted | 3,991 |
| % of Shares Outstanding | Not Available |
| Post-Transaction Ownership | 12,365 ADS (Direct) & 968,978 Ordinary Shares (Direct) |
| Materiality Assessment | Low |
Impact Evaluation
- Market Cap Context: With a market capitalization of $40.48 billion, this $1.52 million sale is negligible and represents only 0.00375% of the company's total value. Such transactions are common for executives at large-cap companies for liquidity or portfolio diversification.
- Transaction Significance: The sale's value is far below the 0.1% of market cap threshold for moderate significance, classifying it as a routine, low-impact event.
Market Impact Analysis
Stock Impact Prediction
- Direction: Neutral
- Reasoning: The transaction size is immaterial relative to the company's market capitalization and daily trading volume. It does not signal a change in the insider's conviction about the company's future prospects.
Volume & Sentiment
- Expected Volume Impact: Minimal. The transaction is not large enough to cause a noticeable spike in trading volume.
- Sentiment Indicator: Neutral. The market is unlikely to react to a sale of this size from a senior executive at a multi-billion dollar company.
Additional Context
Transaction Notes
- The sale was executed in multiple transactions at weighted average prices, as detailed in the filing's footnotes. This is a standard practice for executing larger orders to minimize price impact.
- Each American Depositary Share (ADS) represents 13 Ordinary Shares.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.
